Skip to content
Plan your launch

Launchpad for medtech

From CE mark to hospital purchase orders.

For medical device companies up to two years past CE mark or FDA clearance, building repeatable sales in Europe. A Senior Partner leads every engagement.

HealthSeed

Launchpad · Medtech

  • 6phases, each with a goal
  • 1Senior Partner leads
  • 35+Expert Community specialists

Where medtech launches stall

Approval opens the market. Four steps decide whether you sell in it.

Each of these sits after the CE mark, and each has its own owner, clock, and cost.

  • Notified body and certificate

    Keeping the certificate current through changes, surveillance audits, and the 2026 timeline rules.

    Chapter 8
  • EUDAMED and actor registration

    Manufacturer, authorised representative, importers, and devices, each registered with its own deadline.

    Chapter 9
  • A reimbursement route per country

    Germany, France, and the Netherlands each decide payment their own way, with their own applicant.

    Chapter 13
  • Hospital procurement

    Public buyers purchase through thresholds, procedures, and framework agreements with scoring rules.

    Chapter 15

The Launchpad route

Six phases, each ending in a goal your board can check.

The same route for every Launchpad client; the work inside each phase is set by your device class and your first market.

  1. 01

    Strategy

    Goal: first-market decision and a map of who pays

  2. 02

    Regulatory

    Goal: plan in place, an EU authorised representative appointed

  3. 03

    Market access

    Goal: reimbursement route confirmed

  4. 04

    Customer pilots

    Goal: a hospital pilot agreed, with the terms that turn it into a purchase

  5. 05

    Launch

    Goal: first purchase orders

  6. 06

    Handoff

    Goal: your team runs the next country

Read the evidence first

The medtech chapters of From CE Mark to Revenue.

Our free reference book sets out the rules each phase rests on, with every source linked.

  • Qualification, device class, and roles

    Whether the product is a device, which class applies, and who carries legal responsibility.

    Read chapter 1
  • Device and IVD reimbursement by EU country

    How national routes decide payment, who applies, and who pays.

    Read chapter 13
  • Cost, timeline, and funding of EU market entry

    What entry costs, what each step waits on, and which funding can pay.

    Read chapter 17

What happens next

  1. You tell us your product, its approval, and your first market
  2. A Senior Partner replies with the questions your board will ask
  3. You receive a written proposal for the phases you need

Next step

Talk to a Senior Partner about your device.

Or answer six questions in Plan your launch and see an indicative route first. A Senior Partner reads every enquiry and replies.

Talk to a Senior Partner